GI MOTILITY: A SERIES FROM THE AMS, SERIES #7Irritable Bowel Syndrome: Diagnosis and Management
Irritable Bowel Syndrome (IBS) is a chronic condition which is frustrating to both the patient and the physician. This article gives some of the proposed pathophysiologic mechanisms, guidelines to help make a diagnosis and updated treatment regimens for control of IBS symptoms.
INFLAMMATORY BOWEL DISEASE: A PRACTICAL APPROACH, SERIES #29Prevention of Dysplasia and Cancer in Chronic Inflammatory Bowel Disease: A Role for Chemoprevention
Recent data suggest a role for chemopreventive medications in reducing the risk of colorectal carcinoma (CRC) in patients with chronic inflammatory bowel disease (IBD). This article reviews and summarizes the available evidence regarding chemoprevention of colorectal cancer in patients with IBD.
NUTRITION ISSUES IN GASTROENTEROLOGY, SERIES #48Eosinophilic Gastrointestinal Disorders
Dr. Liacouras' article covers the etiology, clinical features, diagnosis and treatment of three disorders that are defined in large part as eosinophilic gastrointestinal disorders.
THE CELIAC DIET, SERIES #7Combining Diabetes and Gluten-free Dietary Management Guidelines
Celiac disease in children with type 1 diabetes is estimated to be between five and 10 percent The authors offer practical tips for transitioning to a gluten-free, diabetic meal plan.
FELLOWS' CORNERCase Report
A case for you to solve.
The Osler Medical Handbook, 2nd Edition
Piccini JP and Nilsson KR
Elsevier, Saunders, 2006
ISBN: 0323037488; $49.95
When I was first presented with the task of reviewing this book, I thought that a book with Sir William Osler's name on the cover would have to live up to high standards to be worthy of the use of his name.
Sleisenger and Fordtran's Gastrointestinal and Liver Disease, 8th Edition
Feldman M, Friedman LS and Brandt LJ (Editors)
Saunders Elsevier, 2006 (3112 pages 1074 illustrations)
ISBN: 1-4160-0245-6; $279
The 8th edition of this classic text is the first for which neither Drs. Fordtran nor Sleisenger had a first hand role in editing.
Clinical Dilemmas in Inflammatory Bowel Disease
Irving P, Rampton D and Shanahan F (Editor)
Blackwell Publishing Ltd., 2006
ISBN: 1-4051-3377-5; $59.95
The management of Inflammatory Bowel Disease (IBD) is a challenge for gastroenterologists and requires an approach combining both the science and the art of medicine.
New-Onset Diabetes and Pancreatic Cancer
A retrospective cohort study to estimate the incidence of pancreatic cancer subsequent to a new diabetes diagnosis was carried out, to include evaluation of factors associated with subsequent pancreatic cancer diagnosis.
Aminosalicylates in Prevention of Colon Cancer in UC
UC patients with dysplasia or CRC were matched with controls by disease duration, extent and age of diagnosis.
Disease Severity and Therapy for Chronic Hepatitis C
In patients with chronic hepatitis C, advanced fibrosis and cirrhosis are associated with lower rates of sustained virologic response (SVR) to Interferon-based therapy.
Post Colonoscopy U.C. Symptoms
Ulcerative colitis patients often report symptom flares after colonoscopy.
Probiotics in Antibiotic-Associated Diarrhea
To compare the efficacy of probiotics for the prevention of antibiotic-associated diarrhea (AAD), and the treatment of Clostridium difficile disease (CDD), based on the published, randomized controlled clinical trials, searches were made from 1977 to 2005.
FROM THE PEDIATRIC GASTROENTEROLOGY LITERATURE
Noninvasive Testing for Helicobacter Pylori
Infection due to Helicobacter pylori (H. pylori) is thought to occur during childhood, and accurate noninvasive testing is preferable to invasive testing performed by endoscopy and biopsy of the gastric mucosa. The authors of this study attempted to determine the accuracy of 13C-urea breath testing (UBT) and H. pylori stool antigen testing compared to endoscopy and biopsy.
Using Granulocyte Apheresis in Children with Ulcerative Colitis
Granulocyte apheresis is a technique which removes granulocytes and monocytes/macrophages from the blood, and it has been shown to improve the clinical symptoms of patients with ulcerative colitis (UC).
News items of interest to the nation's gastroenterologists.
Topics in this section:
Cook Surgery Reports Significant Hospital Medicare Reimbursement for Promising New Fistula Repair Procedure
A Unique Test for the Rapid Detection of Shiga Toxins from Fecal Specimens Utilizing BioStar« OIA« Technology
FDA Approves LIALDA (mesalamine), the First Oral Once-Daily Mesalamine for Patients with Active, Mild to Moderate Ulcerative Colitis
Spirus Medical Launches Revolutionary System for Colonoscopy
Easy-to-Swallow Konsyl« Psyllium Capsules Provide a Convenient Source of Fiber at 25% the Cost of Competitive Offerings
Sandhill Scientific Announces Distribution Agreement for Noninvasive Liver Fibrosis Diagnostic Technology
Guidelines to Address Support of Families in the ICU